271 related articles for article (PubMed ID: 25691133)
1. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
[TBL] [Abstract][Full Text] [Related]
3. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
4. Herceptin-decorated paclitaxel-loaded poly(lactide-
Zhong S; Ling Z; Zhou Z; He J; Ran H; Wang Z; Zhang Q; Song W; Zhang Y; Luo J
Pharm Dev Technol; 2020 Apr; 25(4):454-463. PubMed ID: 31873051
[TBL] [Abstract][Full Text] [Related]
5. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
6. Nanobubbles for enhanced ultrasound imaging of tumors.
Yin T; Wang P; Zheng R; Zheng B; Cheng D; Zhang X; Shuai X
Int J Nanomedicine; 2012; 7():895-904. PubMed ID: 22393289
[TBL] [Abstract][Full Text] [Related]
7. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
[TBL] [Abstract][Full Text] [Related]
10. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.
Yang H; Cai W; Xu L; Lv X; Qiao Y; Li P; Wu H; Yang Y; Zhang L; Duan Y
Biomaterials; 2015 Jan; 37():279-88. PubMed ID: 25453958
[TBL] [Abstract][Full Text] [Related]
11. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.
Cai WB; Yang HL; Zhang J; Yin JK; Yang YL; Yuan LJ; Zhang L; Duan YY
Sci Rep; 2015 Sep; 5():13725. PubMed ID: 26333917
[TBL] [Abstract][Full Text] [Related]
12. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
13. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Imaging Investigation of Dual-targeted C
Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
[TBL] [Abstract][Full Text] [Related]
15. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
[TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y
Li J; Tian Y; Shan D; Gong A; Zeng L; Ren W; Xiang L; Gerhard E; Zhao J; Yang J; Wu A
Biomaterials; 2017 Feb; 116():106-117. PubMed ID: 27914983
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a novel silicon-modified nanobubble.
Liu J; Zhang B; Li M; Zhou M; Li F; Huang X; Pan M; Xue L; Yan F
PLoS One; 2017; 12(5):e0178031. PubMed ID: 28557995
[TBL] [Abstract][Full Text] [Related]
20. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
